Altimmune, Inc. (ALT) Insider Ownership

Historic Ownership Trends

According to recent filings covering the 90 days ending December 12, 2025, the three most significant insider holders at Altimmune are President And CEO Vipin K Garg (355.08K shares), Chief Financial Officer Gregory L Weaver (23.08K shares), Acting Chief Financial Officer Andrew Shutterly (11.37K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
Healthcare Capital Partners Iii, L.P. Venrock 3,500,000 01 Mar, 2021
Vipin K Garg President And CEO 355,082 03 Feb, 2025
David Drutz 75,675 21 Nov, 2022
M Scot Roberts Chief Scientific Officer 74,066 04 Aug, 2025
Richard I Eisenstadt Chief Financial Officer 45,012 01 Feb, 2024
Raymond M Jordt Chief Business Officer 36,270 04 Aug, 2025
Gregory L Weaver Chief Financial Officer 23,078 12 Nov, 2025
William Michael Brown Chief Financial Officer 17,721 06 Aug, 2021
Matthew Scott Harris Chief Medical Officer 16,087 04 Aug, 2025
Andrew Shutterly Acting Chief Financial Officer 11,372 01 Aug, 2024
Klaus Schafer 9,179 22 Jun, 2022
Philip Hodges 8,731 01 Mar, 2021
Wayne Pisano 8,498 22 Dec, 2022
Catherine A. Sohn 1,000 18 Mar, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
11 Nov, 2025 Gregory L Weaver Common Stock, par value $0.0001 A 18,750 $0.00 28,750 D M
11 Nov, 2025 Gregory L Weaver Common Stock, par value $0.0001 D 5,672 $4.28 23,078 D F
06 Jan, 2022 John Gill Common Stock, par value $0.0001 D 2,714 $0.00 0 D G
06 Jan, 2022 John Gill - - 0 D
31 Jul, 2025 M Scot Roberts Common Stock, par value $0.0001 A 846 $3.14 74,066 D A
31 Jul, 2025 Raymond M Jordt Common Stock, par value $0.0001 A 1,368 $3.14 36,270 D A
31 Jul, 2025 Raymond M Jordt - - 36,270 D
31 Jul, 2025 Matthew Scott Harris Common Stock, par value $0.0001 A 2,018 $3.14 16,087 D A
17 Mar, 2025 Catherine A. Sohn Common Stock, par value $0.0001 A 1,000 $5.78 1,000 D P
17 Mar, 2025 Catherine A. Sohn - - 1,000 D
13 Mar, 2025 Gregory L Weaver Common Stock, par value $0.0001 A 10,000 $5.20 10,000 D P
13 Mar, 2025 Gregory L Weaver - - 10,000 D
07 Mar, 2025 Matthew Scott Harris Common Stock, par value $0.0001 D 67,787 $0.00 14,069 D G
31 Jan, 2025 Raymond M Jordt Common Stock, par value $0.0001 A 2,614 $5.18 34,902 D A
30 Jan, 2025 M Scot Roberts Common Stock, par value $0.0001 A 9,275 $0.00 62,921 D M
30 Jan, 2025 Vipin K Garg - - 342,696 D
30 Jan, 2025 Vipin K Garg Common Stock, par value $0.0001 A 26,775 $0.00 342,696 D M
30 Jan, 2025 Matthew Scott Harris Common Stock, par value $0.0001 A 9,275 $0.00 74,000 D M
30 Jan, 2025 Vipin K Garg - - 330,995 D
30 Jan, 2025 Vipin K Garg Common Stock, par value $0.0001 D 11,701 $7.00 330,995 D F